Roche/GSK Boniva Once-Monthly To Be Launched In April
This article was originally published in The Pink Sheet Daily
Executive Summary
The companies are planning "substantial" DTC ad campaigns, Roche says. FDA approves supplemental NDA for once-monthly ibandronate for treatment of osteoporosis in postmenopausal women. Boniva will be priced competitively to the currently marketed bisphosphonates, Roche says.